Keyphrases
Alzheimer's Disease
100%
Phosphorylated tau
100%
Frontotemporal Lobar Degeneration
100%
Diagnostic Performance
100%
P-tau181
100%
P-tau217
100%
Phosphorylated tau181
100%
Performance Studies
100%
Area under the Curve
69%
Disease Syndrome
46%
Amyloid PET
30%
Tau PET
30%
San Francisco
23%
Clinical Diagnosis
15%
Mild Cognitive Impairment
15%
Tau Pathology
15%
Threonine
15%
University of California
15%
Cognitively Unimpaired
15%
Plasma tau
15%
Neurodegenerative Diseases
7%
Aging
7%
Epitope Specificity
7%
Alzheimer's Disease Diagnosis
7%
Alzheimer's Dementia
7%
Health Departments
7%
Frontotemporal Dementia
7%
Progressive Supranuclear Palsy
7%
Canada
7%
Diagnostic Value
7%
Strong Correlation
7%
Health Care Services
7%
Amyloidosis
7%
Health Status
7%
Plasma Samples
7%
Diagnostic Accuracy
7%
Corticobasal Syndrome
7%
Diverse Populations
7%
Clinical Evaluation
7%
Alzheimer's Association
7%
Temporal Cortex
7%
Receiver Operating Characteristic Analysis
7%
Screening Tool
7%
Non-fluent Aphasia
7%
Differential Diagnosis
7%
Posterior Cortical Atrophy
7%
Cognitive Evaluation
7%
Neuropathological Findings
7%
Background Plasma
7%
Older Cohort
7%
Curve Analysis
7%
Logopenic Progressive Aphasia
7%
Plasma Markers
7%
U.S. National Institutes of Health
7%
Antibody Epitope
7%
Electrochemiluminescence
7%
Semantic Variant Primary Progressive Aphasia
7%
Biotinylated Antibody
7%
State of California
7%
Multi-cohort
7%
Charitable Foundations
7%
Plasma p-tau181
7%
Rainwater
7%
Medicine and Dentistry
Biological Marker
100%
Alzheimer's Disease
100%
Frontotemporal Lobar Degeneration
100%
Diagnostic Performance
100%
Tau
100%
Polyethylene Terephthalate
80%
Amyloid Protein
50%
Primary Progressive Aphasia
30%
Mild Cognitive Impairment
20%
Threonine
20%
Patient with Alzheimer's Disease
20%
Health Service
10%
Health Status
10%
Diagnostic Accuracy
10%
Neurodegenerative Disorder
10%
Epitope
10%
Cerebrospinal Fluid
10%
Progressive Supranuclear Palsy
10%
Diagnosis of Alzheimer's Disease
10%
Temporal Lobe
10%
Posterior Cortical Atrophy
10%
Differential Diagnosis
10%
Frontal Variant Frontotemporal Dementia
10%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Syndrome
100%
Alzheimer's Disease
100%
Polyethylene Terephthalate
72%
Amyloid Protein
45%
Primary Progressive Aphasia
27%
Threonine
18%
Mild Cognitive Impairment
18%
Epitope
9%
Health Status
9%
Progressive Supranuclear Palsy
9%
Fox
9%
Frontal Variant Frontotemporal Dementia
9%
Brain Cortex Atrophy
9%
Neuroscience
Alzheimer's Disease
100%
Blood Plasma
100%
Positron Emission Tomography
72%
Amyloid Protein
45%
Primary Progressive Aphasia
27%
Mild Cognitive Impairment
18%
Threonine
18%
P-Tau217
18%
Neurodegenerative Disorder
9%
Temporal Lobe
9%
Progressive Supranuclear Palsy
9%
Epitope
9%
Differential Diagnosis
9%
Frontal Variant Frontotemporal Dementia
9%
Biochemistry, Genetics and Molecular Biology
Tau
100%
Blood Plasma
100%
Amyloid Protein
50%
Threonine
20%
Health Status
10%
Fox
10%
Electrochemiluminescence
10%